Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 1;22(7):3661.
doi: 10.3390/ijms22073661.

Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System-Implications for Health and Disease

Affiliations
Review

Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System-Implications for Health and Disease

Estefanía Moreno et al. Int J Mol Sci. .

Abstract

The endocannabinoid system (ECS) employs a huge network of molecules (receptors, ligands, and enzymatic machinery molecules) whose interactions with other cellular networks have still not been fully elucidated. Endogenous cannabinoids are molecules with the primary function of control of multiple metabolic pathways. Maintenance of tissue and cellular homeostasis by functional fine-tuning of essential metabolic pathways is one of the key characteristics of the ECS. It is implicated in a variety of physiological and pathological states and an attractive pharmacological target yet to reach its full potential. This review will focus on the involvement of ECS in glucose and lipid metabolism, food intake regulation, immune homeostasis, respiratory health, inflammation, cancer and other physiological and pathological states will be substantiated using freely available data from open-access databases, experimental data and literature review. Future directions should envision capturing its diversity and exploiting pharmacological options beyond the classical ECS suspects (exogenous cannabinoids and cannabinoid receptor monomers) as signaling through cannabinoid receptor heteromers offers new possibilities for different biochemical outcomes in the cell.

Keywords: cancer; cannabinoid receptor; endocannabinoid system; homeostasis; metabolism regulation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
A schematic pictorial model of (a) CB1R and (b) CB2R expression in human organs and tissues according to the Tissue Atlas of the Human Protein Atlas database [10]. mRNA expression overview shows RNA as the consensus dataset based on a combination of three sources—RNA-sequencing data from internally generated Human Protein Atlas (HPA), RNA-sequencing data from the Genotype-Tissue Expression (GTEx) project and Cap Analysis of Gene Expression (CAGE) data from the Functional ANnoTation Of the Mammalian genome 5 (FANTOM5) project. When available protein data for which a knowledge-based annotation gave inconclusive results, no protein expression data were displayed. Nx—Normalized eXpression (resulting transcript expression values calculated for each gene in every sample).
Figure 2
Figure 2
The expression of (a) CB1R and (b) CB2R in human tissues according to the Human Protein Atlas database [10]. mRNA expression overview shows RNA as the consensus dataset based on a combination of three sources—RNA-sequencing data from internally generated Human Protein Atlas (HPA), RNA-sequencing data from the Genotype-Tissue Expression (GTEx) project and Cap Analysis of Gene Expression (CAGE) data from the Functional ANnoTation Of the Mammalian genome 5 (FANTOM5) project. When available protein data for which a knowledge-based annotation gave inconclusive results, no protein expression data were displayed. Nx—Normalized eXpression (resulting transcript expression values calculated for each gene in every sample).
Figure 3
Figure 3
A schematic representation of the role of the endocannabinoid signaling in selected physiological and pathological states.

References

    1. Tsuboi K., Uyama T., Okamoto Y., Ueda N. Endocannabinoids and related N-acylethanolamines: Biological activities and metabolism. Inflamm. Regen. 2018;38:28. doi: 10.1186/s41232-018-0086-5. - DOI - PMC - PubMed
    1. Stasiulewicz A., Znajdek K., Grudzień M., Pawiński T., Sulkowska J.I. A guide to targeting the endocannabinoid system in drug design. Int. J. Mol. Sci. 2020;21:2778. doi: 10.3390/ijms21082778. - DOI - PMC - PubMed
    1. Moreno E., Cavic M., Krivokuca A., Casadó V., Canela E. The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet? Front. Pharmacol. 2019;10:339. doi: 10.3389/fphar.2019.00339. - DOI - PMC - PubMed
    1. Contino M., McCormick P.J. Editorial: The Canonical and Non-Canonical Endocannabinoid System as a Target in Cancer and Acute and Chronic Pain. Front. Pharmacol. 2020;11:312. doi: 10.3389/fphar.2020.00312. - DOI - PMC - PubMed
    1. Alexander S.P.H., Kendall D.A. The complications of promiscuity: Endocannabinoid action and metabolism. Br. J. Pharmacol. 2007;152:602–623. doi: 10.1038/sj.bjp.0707456. - DOI - PMC - PubMed

LinkOut - more resources